Santiago
Moreno Guillén
Catedrático/a de Universidad
University Hospital Bonn
Bonn, AlemaniaPublicaciones en colaboración con investigadores/as de University Hospital Bonn (24)
2024
-
Switch to bictegravir/emtricitabine/tenofovir alafenamide from dolutegravir-based therapy
AIDS (London, England), Vol. 38, Núm. 7, pp. 983-991
2023
-
Hepatitis delta infection among persons living with HIV in Europe
Liver International, Vol. 43, Núm. 4, pp. 819-828
2022
-
HCV reinfection after HCV therapy among HIV/HCV-coinfected individuals in Europe
HIV Medicine, Vol. 23, Núm. 6, pp. 684-692
-
The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study
HIV Medicine, Vol. 23, Núm. 6, pp. 585-598
-
The hepatitis C cascade of care in HIV/hepatitis C virus coinfected individuals in Europe: Regional and intra-regional differences
AIDS, Vol. 36, Núm. 3, pp. 423-435
2021
-
Prevalence and Outcomes for Heavily Treatment-Experienced Individuals Living With Human Immunodeficiency Virus in a European Cohort
Journal of Acquired Immune Deficiency Syndromes, Vol. 87, Núm. 2, pp. 806-817
-
Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study
Annals of Internal Medicine, Vol. 174, Núm. 6, pp. 768-776
2019
-
Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDA
HIV Medicine, Vol. 20, Núm. 4, pp. 264-273
2016
-
Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy
HIV Medicine, Vol. 17, Núm. 6, pp. 471-478
-
Infection-related and -unrelated malignancies, HIV and the aging population
HIV Medicine, Vol. 17, Núm. 8, pp. 590-600
-
Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression: A prospective cohort study
Medicine (United States), Vol. 95, Núm. 40
2015
-
Changing utilization of Stavudine (d4T) in HIV-positive people in 2006-2013 in the EuroSIDA study
HIV Medicine, Vol. 16, Núm. 9, pp. 533-543
-
Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: The Antiretroviral Therapy Cohort Collaboration
Journal of Acquired Immune Deficiency Syndromes, Vol. 69, Núm. 3, pp. 348-354
-
Liver-related death among HIV/hepatitis C virus-co-infected individuals: Implications for the era of directly acting antivirals
AIDS, Vol. 29, Núm. 10, pp. 1205-1215
2014
-
A survey of ATRIPLA use in clinical practice as first-line therapy in HIV-positive persons in Europe
Infection, Vol. 42, Núm. 4, pp. 757-762
-
Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: The D:A:D study
BMC Nephrology, Vol. 15, Núm. 1
-
Immuno-virological discordance and the risk of non-AIDS and AIDS events in a large observational cohort of HIV-patients in Europe
PLoS ONE, Vol. 9, Núm. 1
2013
2012
-
Hepatitis c virus viremia increases the Incidence of chronic kidney disease in HIV-infected Patients
AIDS, Vol. 26, Núm. 15, pp. 1917-1926
-
Regional differences in AIDS and non-AIDS related mortality in HIV-positive individuals across Europe and Argentina: The EuroSIDA study
PLoS ONE, Vol. 7, Núm. 7